NTRA Q3 2019 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$28B

Q3 2019 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$78M+19.3% YoY

Gross Profit

$34M43.7% margin

Operating Income

-$21M-27.1% margin

Net Income

-$23M-29.7% margin

EPS (Diluted)

$-0.33

QoQ Revenue Growth

+4.8%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$14M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$380M

Total Liabilities

$296M

Stockholders' Equity

$85M

Cash & Equivalents

$52M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$78M	$65M	+19.3%
Gross Profit	$34M	$24M	+44.2%
Operating Income	-$21M	-$27M	+22.4%
Net Income	-$23M	-$30M	+21.9%

Revenue Segments

Product

$67M43%

Panorama Nipt

$38M24%

Hcs

$26M17%

Licensing And Other

$11M7%

Bgi Genomics Co Ltd

$7M4%

Other Genetic Tests

$3M2%

Other Licensing And Other

$3M2%

Constellation

$1M1%

Geographic Segments

U

$65M83%

Other Geographic Areas

$9M11%

E M E A

$3M4%

Americas Excluding Us

$806,0001%